Day −2 |
24 h urine collection (baseline) |
Assess MED and apply 3× MED for UVR exposed samples |
Day −1 |
Suction blister (1× no UVR, 1× 3× MED UVR) |
Punch biopsy (1× no UVR, 1× 3× MED UVR) |
Day 0 (supplementation period commenced) |
24 h urine collection (postingestion) |
Plasma pharmacokinetics |
(preingestion: 0 h) |
(postingestion: 0.5, 1, 1.5, 2, 4, 6 h) |
24 h urine collection |
Week 6 |
24 h urine collection |
Week 12, day −1 |
Apply 3× MED UVR |
Week 12 |
Suction blister (1× no UVR, 1× 3× MED UVR; initiated 1 h and samples obtained ~3 h postingestion) |
Punch biopsy (1× no UVR, 1× 3× MED UVR; samples obtained 3 h postingestion) |
Plasma collection (3 h postingestion) |